Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome by Ninive Sanchez
Suitability of the National Health Care
Surveys to Examine Behavioral Health
Services Associated with Polycystic Ovary
Syndrome
Ninive Sanchez, MSW, MS, PhD
Abstract
The National Institutes of Health, Ofﬁce of Disease Prevention, has described polycystic ovary
syndrome (PCOS) as a major public health problem for women in the USA. This study examines
the suitability of the National Health Care Surveys, collected by the Centers for Disease Control
and Prevention, to understand patient demographics and behavioral health services associated
with PCOS-related medical visits. Data were from the 2005–2010 National Ambulatory Medical
Care Survey and National Hospital Ambulatory Medical Care Survey. PCOS-related medical visits
were identiﬁed using the International Classiﬁcation of Diseases, 9th Revision, Clinical
Modiﬁcation code 256.4. Items on mental health and health education ordered or provided did
not meet the National Center for Health Statistics criteria necessary to produce reliable national
estimates (i.e., at least 30 unweighted records and a relative standard error G30%). Findings
underscore the need to strengthen national surveillance to further understand behavioral health
care for patients with PCOS.
Introduction
While the USA has made considerable advances in women’s health, such as reductions in
mortality from chronic diseases like breast cancer and cardiovascular disease, less progress has
been made in the detection and treatment of polycystic ovary syndrome (PCOS).1 The National
Institutes of Health, Ofﬁce of Disease Prevention, has described PCOS as a major public health
problem for women in the USA.2 PCOS is a complex, chronic condition characterized by a range
of symptoms including irregular or no menstrual periods, excess hair growth on the face and body
(hirsutism), weight gain, acne, ovarian cysts, and alopecia.2 PCOS can increase women’s risk of
type 2 diabetes,3 cardiovascular disease,4 infertility,5 anxiety and depression,6–9, and poor health-
related quality of life.10 PCOS can begin in adolescence11 and worsen across the life course if
untreated or poorly managed.12,13
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The prevalence of PCOS among adult women (18 to 45 years of age) in the USA is about
7%.14 However, research with a community sample of women (27 to 34 years of age) in the UK
suggests that the prevalence of PCOS may be even higher, from 7.8 to 20.6%, depending on
which of the three diagnostic criteria for PCOS is used. In addition, using two of these criteria,
NIH and Rotterdam, about 70% of women with PCOS symptoms are undiagnosed.15 Issues
contributing to the lack of diagnosis include differences in diagnosis,15 particularly among
health care providers from different specialties,16 and misperceptions among patients and
providers that cysts in the ovaries are a key feature of PCOS due to the condition’s misleading
name.17 The name suggests that the condition is a problem of the ovaries; however, the presence
of polycystic ovaries alone does not indicate that a woman has PCOS.2 (See the 2012 NIH
Evidence-based Methodology Workshop on PCOS for an overview of diagnostic criteria and
strengths and limitations of each criteria).2 As a result, the 2012 NIH Evidence-based
Methodology Workshop on PCOS recommended establishing Bmultidisciplinary programs to
improve public and health care provider awareness and management for women who currently
have the syndrome^. 2(p. 8)
Although large-scale, epidemiological studies to understand the prevalence, phenotypes, and
morbidities associated with PCOS are currently unavailable,2 national health care data can
provide insight into patient demographics and health care associated with PCOS-related medical
visits. While researchers have questioned whether young adult women with PCOS are Bslipping
through the health care cracks,^18(p. 1) only one study to date has examined health care
associated with PCOS-related medical visits using nationally representative health care data.19 In
that study, Jason used the 2003–2008 data from the National Ambulatory Medical Care Survey
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), collected by
the National Center for Health Statistics, Centers for Disease Control and Prevention, and found
the mean yearly number of PCOS-related medical visits to be 493 per 100,000 women ages 10
to 60 years. Jason found that patients seen for PCOS-related visits tended to be younger, obese,
weigh more, and more likely to be ordered or provided with diet and nutrition counseling,
compared to patients seen for non-PCOS-related visits. The ﬁndings are consistent with the
recommendations from the Androgen Excess and Polycystic Ovary Syndrome Society and
Endocrine Society that lifestyle management (i.e., diet and exercise) should be the ﬁrst line of
treatment for obese women with PCOS.20,21 However, further research is needed to understand
additional patient characteristics and behavioral health services associated with PCOS-related
medical visits. In addition, Jason was unable to calculate national estimates of PCOS-related
visits in which the patient also had a diagnosis of diabetes because these data did not meet the
National Center for Health Statistics criteria necessary to provide reliable estimates. This
underscores the need to further examine whether NAMCS and NHAMCS are suitable to provide
reliable estimates of patient characteristics and behavioral health services associated with PCOS-
related medical visits.
Behavioral health interventions
The U.S. Preventive Services Task Force recommends screening for depression among women,
people with chronic illness, and those with additional mental health disorders.22 Furthermore, the
Centers for Disease Control and Prevention recommend integrating mental health promotion and
mental illness prevention with chronic disease prevention.23 The comorbidity (co-occurrence) of
chronic mental and physical illness poses signiﬁcant burdens to the US population24 and the health
care system.25 This is because comorbidity tends to complicate treatment, affect prognosis, and
limit quality of life.26 For instance, depression, one of the most common mental illnesses seen in
primary care,27 is associated with poor adherence to treatment, increased symptoms, medical costs,
and impairment of daily life (e.g., walking, ability to work), among patients with chronic illness.28
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About one ﬁfth (22.4%) of adults in mental health care drop out of treatment, and patients with
psychiatric comorbidity are likely to drop out by the third visit.29
Research on PCOS suggests that PCOS is comorbid with depression. For instance, research with
women in the USA (M = 35.2 years old) recruited from reproductive endocrine departments and
private practices in the Pittsburgh, Pennsylvania area estimated the prevalence of clinical
depression, based on women’s self-report on the Beck Depression Inventory, to be about 30%
among women with PCOS, compared to 17% among controls.30 Among women with PCOS, those
with higher body mass index, more children, and less education were at greatest risk for mild to
moderate depressive symptoms. In addition, low-income patients with a diagnosis of PCOS based
on the State of Louisiana Medicaid claims were more likely to have a diagnosis of anxiety and
depression compared to a control group.31 Research with trained clinicians has also found that
women with PCOS in Sweden tend to have a higher lifetime incidence of depressive episodes and
social phobia and are more likely to attempt suicide compared to age-matched controls.32
Furthermore, Skype interviews with women with PCOS living in Australia indicate that managing
PCOS in addition to other health conditions can be particularly challenging, leading some women
to develop depressive symptoms, self-harm, and suicidal ideation.33
The Australian Evidence-based Guideline for the Assessment and Management of PCOS
recommends screening and treating patients for anxiety, depression, eating disorders, and poor
body image associated with PCOS symptoms such as hirsutism, acne, obesity, and impaired
fertility. Depression screening, for instance, can prompt intervention to improve emotional well-
being, motivation, and self-efﬁcacy necessary to make lifestyle changes and manage PCOS.34
Health education
Health education is necessary to help patients with PCOS understand their condition and manage
their symptoms.35 Women diagnosed with PCOS report seeing multiple health care providers
before receiving a diagnosis, feeling dissatisﬁed with the information provided to them at the time
of diagnosis,36 and look to the Internet for information on PCOS.37 In addition, patients’
perceptions of the quality of health-related information they receive about PCOS are associated
with their quality of life.38 Research with adolescents with PCOS in the USA found that 32% of
adolescents did not understand PCOS, 48% understood somewhat, and 20% understood the
condition well.39 Additional research with adolescents with PCOS has found that adolescents
express Bworry,^ Bshock,^ Bdisbelief,^ and Bpanic^ at the time of diagnosis; report receiving
inadequate information from providers, particularly in primary care; and do not understand
complex terminology. 40(p. 579) Health education, combined with individualized treatment plans,
inﬂuences patient motivation to implement lifestyle changes to prevent health risks associated with
PCOS.41 Health education in the areas of family planning and contraception, growth and
development, stress management, and tobacco use is relevant to the care of patients with PCOS,
particularly as women have expressed strong interest in nonmedication treatment for PCOS.42
Family planning and contraception
Health education in the areas of family planning and contraception is critical for patients
with PCOS as the condition affects the reproductive system. Examples of the need for health
education in these areas include women’s lack of awareness of infertility and its relationship to
PCOS,43 adolescents’ confusion about PCOS-related infertility and worries about their ability
to have children in the future,39 effects of contraceptives on PCOS symptoms,44 women’s
concerns that contraceptives to induce menstruation result in Bartiﬁcial femininity,^ 45(p. 356)
and the role of oral contraceptives in reducing the risk of developing PCOS-related
endometrial cancer.46
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Growth and development
Research using 1993–2002 NAMCS and NHAMCS has found that increased awareness of
childhood obesity as a public health problem is associated with a shift in the provision of general
growth/development counseling to obesity-related counseling.47 Similarly, PCOS-related growth
and development education can help patients understand the consequences of PCOS across the
lifespan12,13,48 and learn how to manage their symptoms to prevent risks associated with PCOS
such as type 2 diabetes and impaired fertility. When working with adolescents with PCOS,
providers should keep in mind that adolescents appreciate when providers direct discussion toward
them and not just their parents.40 Although PCOS is described as one of the most common
endocrine disorders in women of reproductive age,2 health risks associated with PCOS can persist
postmenopause. For instance, women with PCOS ages 61 to 79 years tend to have a higher
prevalence of hypertension and triglycerides,49 compared to women without PCOS. In addition,
women with PCOS ages 43 to 59 years have a greater likelihood of insulin resistance,50 compared
to similarly aged women without PCOS. These risk factors, combined with cigarette smoking,
obesity, and type 2 diabetes, make women with PCOS susceptible to cardiovascular disease.20
Stress management
Stress management is an important component of health promotion.51 Chronic stress inﬂuences
how individuals cope with and manage poor health,52 and women with PCOS may be more
reactive to stressful experiences (e.g., higher cortisol levels and heart rate) compared to women
without PCOS matched by body mass index.53 Increased awareness of the associations between
stress, coping, mental health, and quality of life among patients with PCOS can prompt additional
mental health screening and stress management counseling. For instance, research with 2005–2010
NAMCS and NHAMCS found that depression screening among adolescents was more likely to
occur if stress management or other mental health counseling was provided.54 Among women with
PCOS, poor coping skills are associated with greater levels of anxiety, depression, and lower
quality of life.55 Patients with PCOS report that stress management techniques in exercise
programs increase sense of control over one’s body and life.56 Incorporating coping strategies into
health education and psychosocial support groups55 and the use of nurse-led peer support groups57
are promising approaches for improving health education and self-management among patients
with PCOS. In addition, there is increased interest in yoga programs that incorporate stress
management techniques to reduce anxiety and improve quality of life among adolescents with
PCOS58–60 and mindfulness approaches that reduce stress and symptoms of depression and anxiety
and increase quality of life among women with PCOS.61
Tobacco use
The Endocrine Society recommends that adolescents and women with PCOS be screened for
cardiovascular disease risk factors, including cigarette smoking.21 Women with PCOS who smoke
tend to have higher triglyceride levels, compared to nonsmokers, even after adjusting for body
mass index.62 In addition, total cholesterol is positively associated with higher amount and duration
of smoking among women with PCOS.63 Furthermore, among obese women with PCOS who
received infertility treatment, couples in which both partners smoked had a lower likelihood of live
birth, compared to nonsmokers.64 Patients with PCOS can beneﬁt from health education and
counseling on the associations between increased age, smoking, metabolic syndrome, and
cardiovascular disease.
This study examines the suitability of NAMCS and NHAMCS to produce reliable national
estimates of patient demographics and behavioral health care associated with PCOS-related
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medical visits. Speciﬁcally, this study examines items on mental health and health education.
Mental health care items include whether the patient had a diagnosis of depression at the time of
the visit, a depression screening exam was ordered or provided, a mental health provider was seen,
psychotherapy was ordered or provided, and other mental health counseling was ordered or
provided at the time of the visit. Items on health education ordered or provided are in the areas of
family planning/contraception, growth/development, stress management, and tobacco use/expo-
sure.
The ﬁndings can identify suppressed data, which refers to data not reported due to their inability
to meet criteria to provide reliable estimates.65 Reports that evaluate the country’s progress in
addressing health and health care disparities, such as the National Healthcare Disparities Report
and Healthy People, suppress data that do not meet reliability criteria.65–67 Suppressed data can
limit our understanding of patient characteristics and behavioral health care associated with PCOS-
related visits.
Method
National health care surveys
This study uses annual, cross-sectional data from the 2005–2010 NAMCS and NHAMCS.
NAMCS and NHAMCS are part of the National Health Care Surveys conducted by the National
Center for Health Statistics, Centers for Disease Control and Prevention.68 NAMCS and NHAMCS
measure several aspects of health care provision and utilization including patient
sociodemographic characteristics, diagnoses, providers seen, and services ordered or provided.
Medical visit information is collected from health care providers in hospitals and clinics located
in the 50 states and the District of Columbia.69,70 Together, NAMCS and NHAMCS provide a
nationally representative sample of ambulatory medical visits in the USA.69 Ambulatory or
outpatient care refers to care in which an individual seeking health services is not currently
admitted (hospitalized) to any health care institution on the premises.
NAMCS
NAMCS collects data on ambulatory care provided by nonfederally employed, ofﬁce-based
physicians primarily engaged in direct patient care. Examples of these ofﬁce settings include
private, solo, or group practices; community health centers; mental health centers; and family
planning clinics. NAMCS utilizes a three-stage design that involves probability samples of primary
sampling units (PSUs) (e.g., a county, a group of counties), physician practices within PSUs, and
medical visits within physician practices.69 There were a total of 180,086 patient record forms in
the 2005–2010 NAMCS.
NHAMCS
NHAMCS collects data on ambulatory care in emergency and outpatient departments (EDs
and OPDs) of noninstitutional, general short-stay (less than 30 days) hospitals, excluding
Federal, military, and Veterans Administration hospitals. Outpatient department refers to a
hospital facility where nonurgent ambulatory medical care is provided under the supervision of a
physician. Emergency department refers to a hospital facility that provides unscheduled
outpatient services to patients whose conditions require immediate care and is staffed 24 hours
a day. Emergency departments open less than 24 hours a day are included as part of the
hospital’s outpatient department. An emergency service area is an area within the emergency
department where emergency services are provided.70
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NHAMCS utilizes a four-stage design that involves probability samples of PSUs, hospitals
within PSUs, clinics/emergency service areas within outpatient/emergency departments, and
patient visits within clinics/emergency service areas.70 From 2005 to 2010, there were a total of
208,956 NHAMCS patient record forms from emergency departments and 201,730 patient record
forms from outpatient departments.
NAMCS and NHAMCS also contain income and education data associated with patients’
residential zip code based on 2000 Census data. In the public use ﬁles, these data are categorized in
quartiles (e.g., median household income) or grouped percentages (e.g., percent of population
below the poverty level).71
Personally identifying information, such as patient names, street addresses, and social security
numbers are not collected in NAMCS and NHAMCS to ensure conﬁdentiality.69,70 This study used
publicly available, deidentiﬁed data and was deemed exempt from review by the University of
Michigan Institutional Review Board.
Measures
This study used data starting from 2005 because that is the year mental health items such as
depression at the time of the visit and depression screening ordered or provided were ﬁrst
introduced in NAMCS and NHAMCS OPD. The item on mental health provider seen was ﬁrst
introduced in the 2007 NAMCS and NHAMCS OPD and in the 2009 NHAMCS ED.72–74
Patient characteristics
Patient sex and race were based on information on the medical record or observation or
knowledge of the patient. Patient sex and race imputed by the National Center for Health Statistics
staff in the 2005–2010 NAMCS and NHAMCS were used in this study.69,70
Sex Sex was coded 1 = female and 0 = male.
Race Race was coded 1 = White (a person having origins in any of the original peoples of
Europe, the Middle East, or North Africa) and 2 = Black or Other (Black refers to a person having
origins in any of the black racial groups of Africa. Other referred to Asian, Native Hawaiian/Other
Paciﬁc Islander, and American Indian/Alaska Native). Although NAMCS and NHAMCS
contained imputed ethnicity variables on ethnicity (Hispanic, not Hispanic), these variables did
not have enough PCOS-related visits to produce reliable estimates.
Age Patient age in years was derived from patient date of birth.
Expected source of payment Private insurance as the expected source of payment was coded
as 1 = Yes and 0 = No. The variable that contained a hierarchy of payment categories
(private insurance, Medicare, Medicaid or Medicaid/SCHIP, worker’s compensation, self-pay,
no charge/charity, other, and unknown) was not used because it did not meet reliability
criteria.
Visit characteristics
Physician’s diagnosis Diagnoses were coded according to the International Classiﬁcation of
Diseases, 9th Revision, Clinical Modiﬁcation (ICD-9-CM).75 Up to three diagnoses were collected
The Journal of Behavioral Health Services & Research 2016
from the provider. In the present study, medical visits were considered PCOS-related if they had a
medical code of 256.4 on any of the three provider diagnoses.
Depression In addition to the diagnoses described above, the provider also indicated the presence
or absence of other conditions at the time of the visit. One of these conditions was depression.
Depression was deﬁned in NAMCS and NHAMCS OPD documentation as affective disorders and
major depressive disorders, such as episodes of depression reaction, psychogenic depression, and
reactive depression. Absence of depression at the time of the visit was coded 0 = No and presence
of depression 1 = Yes.76
Depression screening exam This item indicated whether a depression screening was ordered or
provided at the time of the visit and was coded as 0 = No and 1 = Yes.
Psychotherapy ordered or provided Psychotherapy refers to all treatments involving the
intentional use of verbal techniques to explore or alter the patient’s emotional life in order to
effect symptom reduction or behavior change. Psychotherapy ordered or provided was coded 0 =
No and 1 = Yes.
Other mental health counseling Other mental health counseling refers to general advice and
counseling about mental health issues and education about mental disorders. This includes referrals
to other mental health professionals for mental health counseling.69,70 Other mental health
counseling was coded 0 = No and 1 = Yes.
Mental health provider seen Mental health provider refers to psychologists, counselors, social
workers, and therapists who provide mental health counseling, excluding psychiatrists.72,74 Mental
health provider seen was coded 0 = No and 1 = Yes.
Health education ordered or provided The following types of health education ordered or
provided at the visit were included in this study. Each type of health education ordered or provided
was coded 0 = No and 1 = Yes.
Family planning/contraception. Information given to the patient to assist in the conception or
intended to help the patient understand how to prevent conception.
Growth/development. Topics related to human growth and development.
Stress management. Information intended to help patients reduce stress through activities such as
exercise, biofeedback, and yoga. It also includes referrals to other health professionals for the
purpose of coping with stress.
Tobacco use/exposure. Information given to the patient on issues related to tobacco use in any
use/exposure form, including cigarettes, cigars, snuff, and chewing tobacco, and on the
exposure to tobacco in the form of Bsecondhand smoke.^ This also includes information on
smoking cessation and prevention of tobacco use as well as referrals to other health
professionals for smoking cessation programs.
Sociogeographic characteristics
Starting in 2006, patient zip code in NAMCS and NHAMCS was used with the data from the
2000 Census to determine education, income, and poverty measures.77,78 In the public use ﬁles,
income and education data were categorized in quartiles. These variables were collapsed as follows
in order to meet reliability criteria:
Percent poverty in patient’s zip codewas coded 1 = less than 10% and 2 = greater than or equal to 10%.
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Median household income in patient’s zip code was coded 1 = less than or equal to $40,626 and 2
= greater than or equal to $40,627.
Percent population with bachelor’s degree or higher in patient’s zip code was coded 1 = less than
or equal to 19.66% and 2 = greater than or equal to 19.67%.
Analyses
The 2005 to 2010 NAMCS and NHAMCS ED and OPD data were combined to produce national
estimates of PCOS-related ambulatory medical care in the USA. Analyses were conducted using Stata
13.1 using complex survey commands.79 Patient sampling weights were used to obtain national
estimates of patient visits from 2005 to 2010. The estimated average annual number of patient visits
was obtained by dividing the weighted total estimate of patient visits by 6, the number of years of
survey data used. The Bsvyset^ command in Stata was used to deﬁne the complex sample design and
sampling weights. Between 2005 and 2010, all PCOS-related visits were made by 11- to 60-year-old
females. To conduct analyses on this subpopulation, dummy variables indicating the desired
subpopulation (11- to 60-year-old females) were created, and the Bsubpop()^ function was used to
identify the desired subpopulation. This option takes into account the entire data set in Stata, identiﬁes
the full complex sample design, and performs analyses on the desired subpopulation of data. The Bsvy:
mean^ command was used to compute the estimated mean patient ages and standard errors for PCOS
and non-PCOS-related visits. The Blincom^ command was used after this to test for a difference in
mean age for these two subgroups while still accounting for the complex design and sampling. The
Bsvy: tabulate^ command was used to derive the percentage distributions of PCOS and non-PCOS-
related visits by patient and visit characteristics as well as the associated standard errors. The Rao-Scott
chi-square test was used to test for relations between visit type (PCOS and non-PCOS-related visits)
and patient age, race, private insurance, and geographic characteristics, to account for the complex
sampling design. An alpha level of 0.05 was the criterion for statistical signiﬁcance.
According to the National Center for Health Statistics, reliable estimates are based on at least 30
unweighted records and a relative standard error (standard error divided by estimate) less than
30%. Both conditions should be met before estimates are considered reliable.80 Relative standard
error is calculated by dividing the standard error of the estimate by the estimate itself, then
multiplying that result by 100 to obtain a percent. Relative standard error is expressed as a percent
of the estimate. For example, if the estimate of White patients seen for PCOS-related visits is 70%
and the standard error of the estimate is 6%, the relative standard error of the estimate = (6/70) *
100, or 8.6%. Due to the limited sample size for PCOS-related visits, further advanced multivariate
analyses were not conducted as this would have yielded unreliable estimates.
Results
Between 2005 and 2010, there were 246 unweighted medical records (out of 590,772 total
unweighted records) that had a diagnostic code of PCOS. These 246 visits represent 3,526,716
weighted PCOS-related visits. The mean yearly rate of PCOS-related visits was 587,786 visits; that
is, 306 per 100,000 women ages 11 to 60 years old.
Table 1 describes patient characteristics that met reliability criteria. PCOS-related visits were made
largely by patients who were younger, on average 10 years younger, than patients seen for non-PCOS-
related visits. A larger proportion of White patients (86.9%), who paid with private insurance (82.9%),
were seen for PCOS-related visits. In addition, a greater proportion of PCOS-related visits were made
by patients living in zip codes with percent poverty level greater than 10%. There were no statistically
signiﬁcant associations between visit type and median household income in patient’s zip code or
percent population with a bachelor’s degree or higher in the patient’s zip code.
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Table 2 describes the reliability criteria for items on patient characteristics, and Table 3 describes
the reliability criteria for items on mental health services and health education ordered or provided.
Table 2
Description of reliability criteria for patient characteristics among females ages 11 to 60 years seen








Non-Hispanic White 117 8.3
Non-Hispanic Black 16 43.1
Hispanic 22 29.1
Asian 5 54.6
Native Hawaiian/Other Paciﬁc Islander 4 91.4
American Indian/Alaska Native 1 101.5
Multiple races 3 72.4
Payment type
Private insurance 158 4.8
Medicare 0 0
Medicaid/SCHIP 49 35.5
Worker’s compensation 0 0
Self-pay 19 49.1




Percent poverty in patient’s zip code
Quartile 1 (less than 5%) 39 35.4
Quartile 2 (5 to 9.99%) 58 21.8
Quartile 3 (10 to 19.99%) 72 15.4
Quartile 4 (20% or more) 31 47.1
Median household income in patient’s zip code
Quartile 1 (below $32,793) 42 31.5
Quartile 2 ($32,794–$40,626) 54 20.2
Quartile 3 ($40,627–$52,387) 56 17.4
Quartile 4 ($52,388 or more) 48 24.7
Percent population with bachelor’s degree or higher in patient’s zip code
Quartile 1 (less than 12.84%) 45 34.9
Quartile 2 (12.84 to 19.66%) 49 23.7
Quartile 3 (19.67 to 31.68%) 61 18.2
Quartile 4 (31.69% or more) 45 24.7
Items in italics do not meet the National Center for Health Statistics reliability criteria. Estimates should be
based on at least 30 unweighted records and estimates with a relative standard error (standard error divided by
estimate) less than 30%. Both conditions should be met before estimates are considered reliable
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Discussion
This study is the ﬁrst to examine patient sociodemographics and mental health services and
health education ordered or provided at PCOS-related visits using 2005–2010 NAMCS and
NHAMCS. The number of unweighted records with a diagnosis of PCOS in this study (n = 246) is
Table 3
Description of reliability criteria for mental health care services and health education ordered or







Mental health care services
Depression screening ordered or provided
Yes 6 59.8
No 231 2.1
Depression diagnosis at the time of the visit
Yes 23 35.2
No 214 5.8
Psychotherapy ordered or provided
Yes 4 72.1
No 233 2.4
Mental health provider seen
Yes 1 97.9
No 155 0.2
Other mental health counseling ordered or provided
Yes 2 82.6
No 235 0.6













Items in italics do not meet the National Center for Health Statistics reliability criteria. Estimates should be
based on at least 30 unweighted records and estimates with a relative standard error (standard error divided by
estimate) less than 30%. Both conditions should be met before estimates are considered reliable
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within the range of the number of PCOS-related records Jason found (n = 175) using the 2003–
2008 NAMCS and NHAMCS data.19
Overall, the results of the current study suggest that larger sample sizes of PCOS-related visits
are necessary to understand potential disparities in PCOS-related visits, particularly by insurance




The ages of patients seen for PCOS-related visits (11–60-year olds) in this study reﬂect the
health needs of patients with PCOS across the life span. The ﬁnding that patients seen for PCOS-
related visits were signiﬁcantly younger than patients seen for non-PCOS-related visits is
consistent with Jason’s ﬁndings.19 The results suggest that health services to manage PCOS and
prevent its complications in later life are important, not only among women of reproductive age but
also among children, adolescents, and women postmenopause.
Insurance type
The ﬁnding that the proportion of PCOS-related visits paid with private insurance was higher
than that of PCOS-related visits paid without private insurance mirrors national trends associated
with insurance coverage and health care access and utilization. For instance, according to the
National Healthcare Disparities Report, people with private insurance are about twice as likely to
have a speciﬁc source of ongoing care compared to the uninsured.67 In addition, previous research
with NAMCS and NHAMCS has found delayed transitions in care among young adults with
chronic disease and with public or no health insurance.81 Continuous access to quality, affordable
health services is especially important for patients with a chronic condition such as PCOS that
requires long-term monitoring and care.
Race
A large proportion of PCOS-related visits were by White women. This is concerning as racial
and ethnic minority women may be more susceptible to PCOS and its complications, compared to
White women. For instance, Black women with PCOS tend to have high rates of obesity and
hypertension, followed by Hispanic women; yet, screening for metabolic disorders (e.g., obesity,
high cholesterol, blood pressure, and type 2 diabetes) among racial and ethnic minority women,
and women with PCOS in general, tends to be low.82
Behavioral health services
Reliable estimates of PCOS-related mental health and health education services are necessary to
examine potential disparities in PCOS-related care. Existing health care disparities shed some light
on why some groups have a higher likelihood of referral to, or receipt of, mental health and health
education/counseling services.
Mental health
In the USA, mental health problems are less likely to be recognized and managed in primary
care, compared to specialist care, due to providers’ lack of time, skills, or knowledge of mental
health problems.25 In addition, research using NAMCS and NHAMCS has found that Hispanic
adolescents are less likely to be screened for depression than non-Hispanic, White adolescents,54
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and disparities in diagnosis and treatment of anxiety and depression among African American and
Hispanic adult patients in primary care visits persist.83 Furthermore, research conducted by the
Substance Abuse and Mental Health Services Administration, Health Resources and Services
Administration, and Centers for Medicare and Medicaid Services has identiﬁed lack of
reimbursement for mental health services as one of several barriers to the provision of mental
health services in primary care settings.84
Health education/counseling
Research with the 2005–2007 NAMCS data has also found that while obese patients may
receive diet, exercise, and weight reduction education, they are less likely to receive tobacco
education and psychotherapy referral compared to normal weight patients, suggesting that
behavioral health services may be overlooked if weight alone is seen as the priority.85 Research
with 2005–2010 NAMCS and NHAMCS also suggests that overweight/obese pregnant women are
less likely to receive diet/exercise counseling compared to overweight/obese, nonpregnant
women.86 In addition, disparities in reproductive health services persist, particularly among young,
immigrant women with low education level and underinsured.87 Furthermore, disparities in access
to effective treatment for infertility exist partly due to lack of research on biological causes of
infertility, including PCOS, by race and ethnicity; prolonged duration of infertility prior to seeking
medical advice; and economic barriers such as inability to pay for fertility treatment.88 Research
using 2009–2010 NAMCS has also found low rates of family planning during visits made by
reproductive-aged women, including women with risk factors for cardiovascular disease.89
This study had some limitations. First, as Jason noted, the diagnostic code for PCOS may not
have captured unrecognized cases of PCOS.19 For instance, the lack of standardized, universal
criteria for diagnosing PCOS can lead to inconsistencies and delays in diagnosis. According to the
2012 NIH Evidence-based Methodology Workshop on PCOS, BThe use of multiple classiﬁcation
systems is confusing and delays progress in understanding the syndrome. It also hinders the ability
of clinicians to partner with women to address and manage the health issues that concern them.^
2(p. 2). Second, health education and mental health services ordered may not have been provided at
the time of the visit. However, these items capture an intent to provide these services.90 In addition,
the cross-sectional nature of the surveys used eliminated the ability to assess whether patients had
previously been referred for health education and mental health services or whether they had in the
past discussed preference for these services.
Implications for Behavioral Health
In the USA, low-income populations, racial and ethnic minorities, women, and those with
chronic disease are considered priority populations. The Agency for Healthcare Research and
Quality deﬁnes priority populations as groups with health care needs requiring special attention to
reduce disparities in health care among these populations.67 Health care disparities refer to
differences in health coverage, access to care, and quality of care between populations.91 Low-
income, racial and ethnic minority adolescents and women with PCOS should be included in this
priority.
The ﬁndings underscore the importance of strengthening national surveillance to further
understand patient demographic characteristics and behavioral health care associated with PCOS-
related visits. Effective data collection is an important part of ensuring that people’s health and
mental health needs are met.25 Effective surveillance systems should have sufﬁciently large sample
sizes, even after combining multiple years of data, to make national estimates and conduct analyses
of subgroups.92 In this study, items on mental health services and health education ordered or
provided did not meet reliability criteria, even after combining 6 years of data. Indeed, reviews of
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existing data sources ﬁnd that larger national sample sizes are necessary to identify health
disparities for major racial, ethnic, and socioeconomic subgroups.93 As researchers involved in
developing the ﬁrst National Healthcare Disparities Report stated, BDisparities in data available to
assess the health care of different racial, ethnic, and socioeconomic groups compound the problem
of disparities in access to and quality of care.^ 65(pI-15).
Increased awareness of PCOS and the needs of patients with PCOS can lead to inclusion of
PCOS-related items in national health surveys and larger sample sizes of PCOS-related visits in
the National Health Care Surveys. For instance, as a result of a partnership between the National
Center for Health Statistics and the Health Resources and Services Administration, NAMCS
oversampled community health centers for the ﬁrst time in 2006.94 The oversampling increased
the reliability of estimates for visits to community health centers and led to important ﬁndings
regarding the demographic characteristics of patients visiting community health centers.94–96
Efforts to collect PCOS data on a large scale is also likely to require the support and
endorsement of groups knowledgeable about PCOS research and practice. For instance, in 2010,
NAMCS began collecting data on blood glucose and other laboratory tests related to
cardiovascular disease after the American Heart Association released a scientiﬁc statement
recommending these data be collected to track progress of heart disease and stroke prevention
and management. Including these items in NAMCS provided Ba low-cost approach to enhance
national surveillance for cardiovascular disease^. 69(p. 116) Note that a new item may not be
added to the health care surveys without a sponsoring agency to fund the additional items or if
no expert meeting recommends the addition of items. In addition, the use of paper surveys
means that an item will likely be omitted if a new item is to be added because the paper format
limits the total number of items that can be collected.97 Developing surveillance systems to
understand patient demographics and behavioral health services for patients with PCOS is a
major step in addressing this public health problem for women.
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